MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-07-2024
Alimera Sciences Total Inventories 2011-2026 | ALIM
Annual Total Inventories Alimera Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.88 M | 1.6 M | 2.68 M | 2.75 M | 1.39 M | 2.4 M | 1.51 M | 446 K | 1.55 M | 1.73 M | 1.79 M | 719 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.75 M | 446 K | 1.7 M |
Quarterly Total Inventories Alimera Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.46 M | 2.21 M | 1.88 M | 1.06 M | 1.22 M | 1.6 M | 1.79 M | - | 2.45 M | 2.68 M | 2.3 M | 2.31 M | 2.59 M | 2.75 M | 2.75 M | 2.75 M | 2.75 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 1.51 M | 1.51 M | 1.51 M | 1.51 M | 446 K | 446 K | 446 K | 446 K | 1.55 M | 1.55 M | 1.55 M | 1.55 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 1.79 M | 1.79 M | 1.79 M | 1.79 M | 719 K | 719 K | 719 K | 719 K | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.46 M | 446 K | 1.72 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
13.5 M | $ 40.51 | -0.06 % | $ 1.49 B | USA |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 4.21 | 0.36 % | $ 59.2 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B |  France |
 |
Pacira BioSciences
PCRX
|
125 M | $ 25.03 | -1.82 % | $ 1.16 B | USA |
 |
Jupiter Wellness
JUPW
|
949 K | - | - | $ 33.6 M | USA |
 |
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 1.16 | 5.45 % | $ 1.44 M | USA |
 |
Bausch Health Companies
BHC
|
1.54 B | $ 5.56 | -2.88 % | $ 2.03 B |  Canada |
 |
Tilray
TLRY
|
201 M | $ 6.21 | -0.48 % | $ 3.84 B | Canada |
 |
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.12 | 0.91 % | $ 120 M | Canada |
 |
Veru
VERU
|
4.14 M | $ 2.28 | 1.33 % | $ 308 M | USA |
 |
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
27 M | $ 5.36 | -0.56 % | $ 346 M | USA |
 |
Emergent BioSolutions
EBS
|
329 M | $ 8.4 | 2.07 % | $ 430 M | USA |
 |
Organogenesis Holdings
ORGO
|
26.2 M | $ 2.46 | 4.68 % | $ 324 M | USA |
 |
cbdMD
YCBD
|
2.52 M | $ 0.81 | -6.57 % | $ 3.49 M | USA |
 |
ProPhase Labs
PRPH
|
3.98 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
24.1 M | $ 18.45 | 0.1 % | $ 118 M | USA |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 1.0 | 6.99 % | $ 49.9 M | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
3.52 B | $ 14.9 | -0.3 % | $ 17.9 B | USA |
 |
Zomedica Corp.
ZOM
|
5.54 M | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
3.42 M | $ 0.87 | -1.25 % | $ 31.3 M | USA |
 |
China Pharma Holdings
CPHI
|
1.62 M | $ 0.53 | -1.07 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 2.07 | 1.47 % | $ 23.9 M | USA |